K Peggs
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 10
-
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Simon J. Davidson (1 shared paper)Timothy James Littlewood (1 shared paper)Ronjon K. Chakraverty (1 shared paper)Christopher S. Garrard (1 shared paper)Emma C. Morris (6 shared papers)Kirsty J. Thomson (3 shared papers)Stephen Mackinnon (8 shared papers)Jim Cavet (2 shared papers)
- Journals
- Bone Marrow Transplantation (4 papers)Cytotherapy (1 paper)Hematological Oncology (1 paper)Annals of Oncology (1 paper)Leukemia (1 paper)
- Partner nations
- United KingdomItalySpain
In The Last Decade
K Peggs
21 papers receiving 352 citations
Peers
Comparison fields: 5 of 40
- Hematology 121
- Pathology and Forensic Medicine 156
- Oncology 142
- Internal Medicine 16
- Genetics 48
Countries citing papers authored by K Peggs
This map shows the geographic impact of K Peggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Peggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Peggs more than expected).
Fields of papers citing papers by K Peggs
This network shows the impact of papers produced by K Peggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Peggs. The network helps show where K Peggs may publish in the future.
Co-authors
The 25 scholars most cited alongside K Peggs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 96 | |
| 2 | 2008 | 82 | |
| 3 | 2001 | 44 | |
| 4 | 2016 | 44 | |
| 5 | 2012 | 27 | |
| 6 | ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells | 2018 | 20 |
| 7 | 2011 | 9 | |
| 8 | 2007 | 7 | |
| 9 | Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation. | 2000 | 6 |
| 10 | 2016 | 6 | |
| 11 | Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. | 2003 | 5 |
| 12 | Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. | 2001 | 4 |
| 13 | 2017 | 3 | |
| 14 | Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). | 2002 | 2 |
| 15 | Reduced intensity conditioned allogeneic stem cell transplantation (RIC-Allo) as front-line therapy for mantle cell lymphoma (MCL): Results from the UK Phase II Mini Allo Study (CRUK: C7627/A9080) | 2016 | 2 |
| 16 | Non-myeloablative conditioning limits transplant related mortality in patients who have previously failed high dose treatment. | 2000 | 1 |
| 17 | CAMPATH-1H-containing nonmyeloablative allogeneic stem cell transplantation for myeloma results in delayed T cell reconstitution and a high incidence of viral infections, but low infection-related mortality. | 2001 | 1 |
| 18 | 2004 | 1 | |
| 19 | Favourable outcome for haematopoietic transplant recipients requiring intensive therapy unit admission: a 10-year single-centre experience | 2009 | 1 |
| 20 | AUTOLOGOUS STEM CELL TRANSPLANTATION REMAINS BENEFICIAL FOR PATIENTS RELAPSING AFTER R-CHOP AND WHO RESPOND TO SALVAGE CHEMOTHERAPY | 2011 | 1 |
About K Peggs
K Peggs is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Philosophy and Neurology, having authored 22 papers that have together received 363 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (5 papers), Health, Medicine and Society (4 papers), Hermeneutics and Narrative Identity (4 papers), Aging, Elder Care, and Social Issues (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Hematology (121 citations), Pathology and Forensic Medicine (156 citations), Oncology (142 citations), Internal Medicine (16 citations) and Genetics (48 citations). K Peggs has collaborated with scholars based in United Kingdom, Italy and Spain. Frequent co-authors include Simon J. Davidson, Timothy James Littlewood, Ronjon K. Chakraverty, Christopher S. Garrard, Emma C. Morris, Kirsty J. Thomson, Stephen Mackinnon, Jim Cavet, D W Milligan and Anthony H. Goldstone. Their work appears in journals such as Bone Marrow Transplantation, Cytotherapy, Hematological Oncology, Annals of Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.